Prolonged-course tuberculosis treatment or secondary prevention for those at high risk of recurrence?

Moore, David P; Hesseling, Anneke C; Marx, Florian M

Moore, David P; Hesseling, Anneke C; Marx, Florian M.

Afiliação

Moore DP; Department of Paediatrics & Child Health, Chris Hani Baragwanath Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa; Vaccines and Infectious Diseases Analytics (VIDA) Research Unit, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: david.moore@wits.ac.za.
Hesseling AC; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Marx FM; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa; DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.

Clin Microbiol Infect ; 28(5): 631-633, 2022 05.

Article em En | MEDLINE | ID: mdl-35124263

Assuntos

Mycobacterium tuberculosis; Tuberculose Resistente a Múltiplos Medicamentos; Antituberculosos/uso terapêutico; Humanos; Recidiva; Prevenção Secundária; Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico

Palavras-chave

Programmatic management; Secondary prevention; TB recurrence; Treatment duration; Tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Microbiol Infect Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google